TLX3
T-cell leukemia homeobox protein 3
Also known as: HOX11L2, RNX, TLX3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43711
- Gene
- TLX3
- Ensembl
- ENSG00000164438
- Chromosome
- 5
- Canonical length
- 291 aa
- Protein class
- Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is an orphan homeobox protein that encodes a DNA-binding nuclear transcription factor. A translocation [t(5;14)(q35;q32)] involving this gene is associated with T-cell acute lymphoblastic leukemia (T-ALL) in children and young adults. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
291 residues, UniProt reviewed canonical sequence.
>O43711|TLX3
1 MEAPASAQTP HPHEPISFGI DQILNSPDQD SAPAPRGPDG ASYLGGPPGG RPGATYPSLP
61 ASFAGLGAPF EDAGSYSVNL SLAPAGVIRV PAHRPLPGAV PPPLPSALPA MPSVPTVSSL
121 GGLNFPWMES SRRFVKDRFT AAAALTPFTV TRRIGHPYQN RTPPKRKKPR TSFSRVQICE
181 LEKRFHRQKY LASAERAALA KSLKMTDAQV KTWFQNRRTK WRRQTAEERE AERQQASRLM
241 LQLQHDAFQK SLNDSIQPDP LCLHNSSLFA LQNLQPWEED SSKVPAVTSL VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TLX3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 24 nTPM
- spinal cord: 1.5 nTPM
- pituitary gland: 0.3 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- extravillous trophoblasts: 11 nCPM
- oocytes: 4.6 nCPM
- brain excitatory neurons: 4.5 nCPM
- migrating cytotrophoblasts: 1.3 nCPM
- breast lactating cells: 0.6 nCPM
- thyrotrophs: 0.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 19 nTPM
- spinal cord: 11 nTPM
- medulla oblongata: 5 nTPM
- pons: 2.1 nTPM
- white matter: 0.9 nTPM
- cerebral cortex: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0.26
- gnomAD missense Z
- 1.4
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ development
- central nervous system development
- GABAergic neuron differentiation
- negative regulation of neuron differentiation
- neuron fate specification
- neuron migration
- regulation of respiratory gaseous exchange by nervous system process
- regulation of transcription by RNA polymerase II
- respiratory gaseous exchange by respiratory system
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TLX3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TLX3 as an antibody target. Whether an autoantibody or antibody against TLX3 could matter depends on whether native TLX3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TLX3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TLX3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...